<!DOCTYPE html>
<html lang="cs">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Insilico Medicine z Qiming Venture Partners ÃºspÄ›Å¡nÄ› uvedena na burze v Hong Kongu | Marigold.cz Tech News</title>
    <meta name="description" content="SpoleÄnost Insilico Medicine, lÃ­dr v objevovÃ¡nÃ­ lÃ©kÅ¯ pohÃ¡nÄ›nÃ©m AI a portfolio firma Qiming Venture Partners, dnes ÃºspÄ›Å¡nÄ› vstoupila na burzu v Hong Kongu. JednÃ¡">
    <link rel="canonical" href="https://www.marigold.cz/tech-news/2025-12-31/qiming-venture-partners-insilico-medicine-successf/">
    <style>
        * { margin: 0; padding: 0; box-sizing: border-box; }
        body { font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif; line-height: 1.6; color: #374151; background: #f3f4f6; }
        .container { max-width: 800px; margin: 0 auto; padding: 2rem; }
        .tech-news-article { background: white; border-radius: 12px; box-shadow: 0 4px 6px rgba(0,0,0,0.1); padding: 2rem; margin: 2rem 0; }
        .source-info { display: flex; align-items: center; gap: 0.75rem; margin-bottom: 1rem; flex-wrap: wrap; }
        .source-emoji { font-size: 1.5rem; }
        .source-name { font-weight: 600; color: #374151; }
        .importance-indicator { display: flex; gap: 2px; margin-left: auto; }
        .star { color: #fbbf24; font-size: 1.2rem; }
        .star.empty { color: #d1d5db; }
        .article-title { font-size: 2rem; font-weight: 700; line-height: 1.2; margin-bottom: 1rem; color: #111827; }
        .article-meta { display: flex; align-items: center; gap: 1rem; font-size: 0.875rem; color: #6b7280; margin-bottom: 1.5rem; }
        .category { padding: 0.25rem 0.75rem; border-radius: 1rem; font-weight: 500; font-size: 0.75rem; text-transform: uppercase; background: #e5e7eb; color: #374151; }
        .article-image { margin: 1.5rem 0; border-radius: 8px; overflow: hidden; }
        .article-image img { width: 100%; height: auto; display: block; }
        .article-content { font-size: 1.125rem; line-height: 1.7; margin-bottom: 2rem; }
        .article-content h2 { font-size: 1.5rem; margin: 1.5rem 0 1rem; color: #111827; }
        .article-content p { margin-bottom: 1rem; }
        .article-footer { border-top: 1px solid #e5e7eb; padding-top: 1.5rem; }
        .read-more-btn { display: inline-flex; align-items: center; gap: 0.5rem; padding: 0.75rem 1.5rem; background: #3b82f6; color: white; text-decoration: none; border-radius: 8px; font-weight: 500; }
        .read-more-btn:hover { background: #2563eb; }
        .original-title { margin-top: 1rem; color: #6b7280; font-size: 0.875rem; }
        .back-link { display: inline-block; margin-bottom: 1rem; color: #3b82f6; text-decoration: none; }
        .back-link:hover { text-decoration: underline; }
        .archive-notice { background: #fef3c7; border: 1px solid #f59e0b; border-radius: 8px; padding: 1rem; margin-bottom: 1rem; font-size: 0.875rem; color: #92400e; }
        @media (max-width: 640px) {
            .container { padding: 1rem; }
            .tech-news-article { padding: 1.5rem; margin: 1rem 0; }
            .article-title { font-size: 1.5rem; }
            .source-info { flex-direction: column; align-items: flex-start; }
            .importance-indicator { margin-left: 0; margin-top: 0.5rem; }
        }
    </style>
</head>
<body>
    <div class="container">
        <a href="/tech-news/" class="back-link">&larr; ZpÄ›t na Tech News</a>

        <div class="archive-notice">
            Tento ÄlÃ¡nek je z archivu. Byl publikovÃ¡n 31.12.2025.
        </div>

        <article class="tech-news-article">
            <header>
                <div class="source-info">
                    <span class="source-emoji">ğŸ“°</span>
                    <span class="source-name">PR Newswire UK</span>
                    <div class="importance-indicator">
                        <span class="star">â˜…</span><span class="star">â˜…</span><span class="star">â˜…</span><span class="star">â˜…</span><span class="star empty">â˜†</span>
                    </div>
                </div>

                <h1 class="article-title">Insilico Medicine z Qiming Venture Partners ÃºspÄ›Å¡nÄ› uvedena na burze v Hong Kongu</h1>

                <div class="article-meta">
                    <time datetime="2025-12-31T01:14:00+00:00">31.12.2025</time>
                    <span class="category">biotechnologie</span>
                </div>
            </header>

            

            <div class="article-content">
                <h2>Souhrn</h2>
<p>SpoleÄnost Insilico Medicine, specializujÃ­cÃ­ se na objev lÃ©kÅ¯ za pomoci umÄ›lÃ© inteligence, dokonÄila ÃºspÄ›Å¡nÃ© uvedenÃ­ na burze v Hong Kongu (kÃ³d 03696.HK). Akcie se otevÅ™ely na 35 HKD pÅ™i emisnÃ­ cenÄ› 24,05 HKD, coÅ¾ pÅ™edstavuje trÅ¾nÃ­ kapitalizaci kolem 19,51 miliardy HKD. Firma je podporovÃ¡na investorem Qiming Venture Partners, kterÃ½ drÅ¾Ã­ pÅ™ibliÅ¾nÄ› 7% podÃ­lu.</p>
<h2>KlÃ­ÄovÃ© body</h2>
<ul>
<li>NejvÄ›tÅ¡Ã­ IPO v biotechnologiÃ­ch na hongkongskÃ© burze v roce 2025.</li>
<li>Platforma Pharma.AI slouÅ¾Ã­ k urychlenÃ©mu objevovÃ¡nÃ­ lÃ©kÅ¯ v oblastech jako onkologie, imunologie a metabolickÃ© poruchy.</li>
<li>PartnerstvÃ­ s 13 z 20 nejvÄ›tÅ¡Ã­ch farmaceutickÃ½ch firem svÄ›ta a licenÄnÃ­ dohody s potenciÃ¡lem pÅ™Ã­jmÅ¯ 2 miliardy USD.</li>
<li>Qiming Venture Partners vedl sÃ©rie B, C a D financovÃ¡nÃ­ od roku 2019.</li>
<li>Pipeline zahrnuje pÅ™es 30 inovativnÃ­ch projektÅ¯, vÄetnÄ› prvnÃ­ch AI-generovanÃ½ch lÃ©kÅ¯ ve svÄ›tÄ›.</li>
</ul>
<h2>Podrobnosti</h2>
<p>Insilico Medicine, zaloÅ¾enÃ¡ v roce 2014, vyvinula platformu Pharma.AI, kterÃ¡ integruje umÄ›lou inteligenci do celÃ©ho procesu vÃ½voje lÃ©kÅ¯ â€“ od identifikace cÃ­lovÃ½ch molekul pÅ™es predikci toxicity aÅ¾ po nÃ¡vrh klinickÃ½ch studiÃ­. Tato platforma umoÅ¾Åˆuje vÃ½raznÄ› zkrÃ¡tit Äas a nÃ¡klady na vÃ½voj, kterÃ© v tradiÄnÃ­ farmacii trvajÃ­ Äasto deset let a stojÃ­ stovky milionÅ¯ dolarÅ¯. Firma rozÅ¡Ã­Å™ila Pharma.AI i do dalÅ¡Ã­ch oblastÃ­, jako jsou pokroÄilÃ© materiÃ¡ly, zemÄ›dÄ›lstvÃ­, vÃ½Å¾ivovÃ© doplÅˆky a veterinÃ¡rnÃ­ lÃ©ky, coÅ¾ ukazuje na flexibilitu AI modelÅ¯ v generovÃ¡nÃ­ molekulÃ¡rnÃ­ch struktur.</p>
<p>PÅ™ed IPO vlastnil Qiming Venture Partners, ÄÃ­nskÃ½ venture kapitÃ¡lovÃ½ fond zamÄ›Å™enÃ½ na technologie a healthcare, asi 7% akciÃ­. Tento investor vedl klÃ­ÄovÃ© kola financovÃ¡nÃ­: sÃ©rii B v roce 2019 a nÃ¡slednÄ› C a D, coÅ¾ pomohlo Insilico vybudovat robustnÃ­ pipeline s vÃ­ce neÅ¾ 30 projekty. Mezi nimi jsou prvnÃ­-in-class lÃ©ky zaloÅ¾enÃ© na AI, cÃ­lenÃ© na vysokÃ© zdravotnÃ­ potÅ™eby v onkologii, imunologii, fibrÃ³ze a metabolickÃ½ch onemocnÄ›nÃ­ch.</p>
<p>Komercializace probÃ­hÃ¡ pÅ™es partnerstvÃ­: 13 z 20 nejvÄ›tÅ¡Ã­ch farmaceutickÃ½ch firem podle obratu, vÄetnÄ› Sanofi, Lilly a Shanghai Fosun Pharmaceutical, spolupracuje na softwarovÃ© platformÄ›. Firma uzavÅ™ela licenÄnÃ­ smlouvy na tÅ™i pipeline s globÃ¡lnÃ­mi hrÃ¡Äi jako Exelixis a Menarini, s potenciÃ¡lem pÅ™Ã­jmÅ¯ 2 miliardy USD. Tyto dohody zahrnujÃ­ milestone platby a royalties z prodejÅ¯, coÅ¾ poskytuje Insilico stabilnÃ­ cash flow bez nutnosti plnÃ©ho financovÃ¡nÃ­ klinickÃ½ch fÃ¡zÃ­.</p>
<p>IPO na HKEX probÄ›hlo 31. prosince 2025 v Å anghaji oznÃ¡menÃ© prostÅ™ednictvÃ­m PRNewswire. EmisnÃ­ cena 24,05 HKD vedla k otevÅ™enÃ­ na 35 HKD, coÅ¾ signalizuje silnÃ½ zÃ¡jem investorÅ¯ o AI v healthcare. TrÅ¾nÃ­ kapitalizace 19,51 miliardy HKD umisÅ¥uje Insilico mezi vÃ½znamnÃ© biotech hrÃ¡Äe v Asii, kde tradiÄnÄ› dominujÃ­ ÄÃ­nskÃ© firmy dÃ­ky rychlÃ©mu rÅ¯stu AI ekosystÃ©mu.</p>
<h2>ProÄ je to dÅ¯leÅ¾itÃ©</h2>
<p>Toto IPO podtrhuje zralost AI v objevovÃ¡nÃ­ lÃ©kÅ¯, kde modely jako ty v Pharma.AI pÅ™ekonÃ¡vajÃ­ tradiÄnÃ­ screening metody v rychlosti a Ãºspornosti. Pro prÅ¯mysl znamenÃ¡ validaci modelu: ÃºspÄ›Å¡nÃ© partnerstvÃ­ s Big Pharma ukazujÃ­, Å¾e AI nenÃ­ jen hype, ale generuje reÃ¡lnÃ© kandidÃ¡ty na lÃ©ky. V Å¡irÅ¡Ã­m kontextu posiluje to pozici Hong Kongu jako centra pro biotech IPO v Asii, kde regulace podporujÃ­ tech-healthcare fÃºze. Pro investory a vÃ½vojÃ¡Å™e AI otevÃ­rÃ¡ dveÅ™e k dalÅ¡Ã­m fundingÅ¯m v oblasti precision medicine, kde AI mÅ¯Å¾e snÃ­Å¾it selhÃ¡nÃ­ v klinickÃ½ch testech z 90 % na niÅ¾Å¡Ã­ ÃºrovnÄ›. Kriticky Å™eÄeno, ÃºspÄ›ch zÃ¡visÃ­ na tom, zda AI-generovanÃ© lÃ©ky projdou regulaÄnÃ­ schvÃ¡lenÃ­ FDA nebo EMA, coÅ¾ zatÃ­m zÅ¯stÃ¡vÃ¡ vÃ½zvou pro celÃ½ sektor.</p>
<hr />
<p><a href="https://www.prnewswire.co.uk/news-releases/qiming-venture-partners-insilico-medicine-successfully-lists-on-hong-kong-stock-exchange-302650996.html">ÄŒÃ­st pÅ¯vodnÃ­ ÄlÃ¡nek</a></p>
<p><strong>Zdroj:</strong> ğŸ“° PR Newswire UK</p>
            </div>

            <footer class="article-footer">
                <a href="https://www.prnewswire.co.uk/news-releases/qiming-venture-partners-insilico-medicine-successfully-lists-on-hong-kong-stock-exchange-302650996.html" target="_blank" rel="noopener" class="read-more-btn">
                    ÄŒÃ­st pÅ¯vodnÃ­ ÄlÃ¡nek &rarr;
                </a>

                <div class="original-title"><small>PÅ¯vodnÃ­ nÃ¡zev: Qiming Venture Partners' Insilico Medicine Successfully Lists on Hong Kong Stock Exchange</small></div>
            </footer>
        </article>

        <p style="text-align: center; color: #6b7280; font-size: 0.875rem; margin-top: 2rem;">
            &copy; 2026 <a href="https://www.marigold.cz" style="color: #3b82f6;">Marigold.cz</a>
        </p>
    </div>
</body>
</html>
